Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Liang Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1954-4345; OpenAlex author ID A5110033263. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. Genetically predicted blood metabolites mediate the association between circulating inflammation-related proteins and pancreatic cancer Co-author DOI 10.21203/rs.3.rs-5783157/v1↗
  2. LncRNA CTD-3252C9.4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription. Co-author DOI 10.1186/s12935-021-02142-0↗
  3. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Co-author PMID 32064152↗
  4. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Co-author DOI 10.1111/cpr.12568↗
  5. Transcriptome Profiling of Panc-1 Spheroid Cells with Pancreatic Cancer Stem Cells Properties Cultured by a Novel 3D Semi-Solid System. Last author DOI 10.1159/000491479↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Pan · 4 shared papers, 2018–2021 · strength 0.43
  2. Yanheng Duan · 1 shared paper, 2025 · strength 0.26
  3. Yong Chen · 1 shared paper, 2025 · strength 0.26
  4. Jiaze An · 1 shared paper, 2025 · strength 0.26
  5. Xin Yin · 2 shared papers, 2018–2021 · strength 0.21
  6. Zhaocong Yang · 2 shared papers, 2018–2020 · strength 0.20
  7. Manman Li · 1 shared paper, 2020 · strength 0.12
  8. Rongtao Zhou · 1 shared paper, 2019 · strength 0.10
  9. Chun‐Bo Teng · 1 shared paper, 2019 · strength 0.10
  10. Jin‐San Zhang · 1 shared paper, 2019 · strength 0.10
  11. Ze Yu · 1 shared paper, 2019 · strength 0.10
  12. Sheng Tai · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.